Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pitavastatin With Ezetimibe Combination Therapy Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

NCT07626840 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07626840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07626840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pitavastatin With Ezetimibe Combination Therapy Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 31, 2031
Enrollment
5,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs) undergoing percutaneous coronary intervention (pci)